Speaker illustration

Mr Xabier Arana

Donostia University Hospital, Donostia (Spain)

Prognostic impact of diagnosis of transthyretin cardiac amyloidosis

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Chronic Heart Failure 2

Thumbnail

What is characteristic of transthyretin cardiac amyloidosis on imaging techniques?

Event: Heart Failure 2021

Topic: Imaging

Session: ePoster session

Thumbnail

Transthyretin cardiac amyloidosis: what are the main clinical suspicion data?

Event: Heart Failure 2021

Topic: Hypertrophic Cardiomyopathy

Session: ePoster session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb